It is our hope and dream to help patients and family who are in need of better treatment options to fight against orphan/intractable diseases.


It is our mission to execute late-stage research and early development projects with agility and taking risks in true spirit of entrepreneurship to deliver much needed medicines. We will always consider patients first and are committed to deliver.


Accelerate R&D process by extensive external partnership, such as participation in publically funded initiatives to treat intractable diseases

  1. By drug repositioning to maintain high R&D productivity
  2. By delivering medicines for orphan and intractable diseases
  3. 3.Deliver GPCR modulators as drugs that have higher chance of success